Dyne Therapeutics Cash Flow Statement
NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.64+0.27 (+1.65%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dyne Therapeutics free cash flow
In fiscal 2025, Dyne Therapeutics generated -$403.2 million of operating cash flow and spent $1.9 million on capital expenditures. That left free cash flow of -$405.1 million.
Summary generated from market data by MetaCap's automated system. Methodology
Dyne Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -446.21M | -317.42M | -235.94M | -168.10M | -149.29M | -59.44M | -14.86M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.05M | 1.67M | 1.67M | 1.68M | 1.09M | 700.00K | 271.00K |
| Stock-Based Compensation | 45.85M | 45.86M | 19.97M | 15.18M | 17.54M | 6.59M | 26.00K |
| Change in Working Capital | 986.00K | -10.54M | 3.34M | -4.14M | -1.51M | -3.46M | -284.00K |
| Operating Cash Flow | -403.21M | -292.37M | -188.16M | -153.65M | -119.56M | -46.51M | -11.83M |
| Capital Expenditures | -1.92M | -2.38M | -729.00K | -3.07M | -3.62M | -1.16M | -1.65M |
| Investing Cash Flow | -28.75M | -204.08M | 83.31M | 87.20M | -137.89M | -45.66M | -1.65M |
| Debt Issued | 148.26M | 0 | 0 | — | — | 9.94M | — |
| Debt Repaid | — | — | — | — | — | -10.00M | — |
| Financing Cash Flow | 890.31M | 809.89M | 54.32M | 37.39M | 157.82M | 380.69M | 19.99M |
| Net Change in Cash | 458.35M | 313.45M | -50.52M | -29.05M | -99.63M | 288.52M | 6.51M |
| Free Cash Flow | -405.13M | -294.75M | -188.89M | -156.71M | -123.18M | -47.67M | -13.48M |
This table shows 7 annual periods of Dyne Therapeutics's cash flow statement, from FY 2025 back to FY 2019, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DYN's reporting calendar. What is a cash flow statement?